nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CACNA1S—pes—psoriatic arthritis	0.204	0.858	CbGeAlD
Isradipine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0415	0.248	CbGbCtD
Isradipine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0314	0.188	CbGbCtD
Isradipine—CYP3A4—Betamethasone—psoriatic arthritis	0.027	0.161	CbGbCtD
Isradipine—CYP3A4—Prednisolone—psoriatic arthritis	0.0266	0.159	CbGbCtD
Isradipine—CYP3A4—Prednisone—psoriatic arthritis	0.0251	0.15	CbGbCtD
Isradipine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0157	0.0938	CbGbCtD
Isradipine—CACNA1S—tendon—psoriatic arthritis	0.0156	0.0657	CbGeAlD
Isradipine—CACNB2—tendon—psoriatic arthritis	0.00938	0.0395	CbGeAlD
Isradipine—CACNA2D1—tendon—psoriatic arthritis	0.00881	0.0371	CbGeAlD
Isradipine—Myocardial infarction—Prednisone—psoriatic arthritis	0.00186	0.00312	CcSEcCtD
Isradipine—Breast disorder—Methotrexate—psoriatic arthritis	0.00186	0.00312	CcSEcCtD
Isradipine—Malaise—Prednisolone—psoriatic arthritis	0.00184	0.00309	CcSEcCtD
Isradipine—Syncope—Prednisolone—psoriatic arthritis	0.00183	0.00307	CcSEcCtD
Isradipine—Eye disorder—Dexamethasone—psoriatic arthritis	0.00183	0.00307	CcSEcCtD
Isradipine—Eye disorder—Betamethasone—psoriatic arthritis	0.00183	0.00307	CcSEcCtD
Isradipine—Back pain—Triamcinolone—psoriatic arthritis	0.00181	0.00305	CcSEcCtD
Isradipine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00179	0.00301	CcSEcCtD
Isradipine—Angiopathy—Betamethasone—psoriatic arthritis	0.00177	0.00298	CcSEcCtD
Isradipine—Angiopathy—Dexamethasone—psoriatic arthritis	0.00177	0.00298	CcSEcCtD
Isradipine—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00174	0.00292	CcSEcCtD
Isradipine—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00173	0.00291	CcSEcCtD
Isradipine—Bradycardia—Prednisone—psoriatic arthritis	0.00173	0.00291	CcSEcCtD
Isradipine—Discomfort—Prednisolone—psoriatic arthritis	0.00171	0.00288	CcSEcCtD
Isradipine—Angioedema—Triamcinolone—psoriatic arthritis	0.00171	0.00288	CcSEcCtD
Isradipine—Angioedema—Methylprednisolone—psoriatic arthritis	0.00171	0.00287	CcSEcCtD
Isradipine—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.0017	0.00286	CcSEcCtD
Isradipine—Malaise—Triamcinolone—psoriatic arthritis	0.00169	0.00284	CcSEcCtD
Isradipine—Malaise—Methylprednisolone—psoriatic arthritis	0.00169	0.00283	CcSEcCtD
Isradipine—Syncope—Triamcinolone—psoriatic arthritis	0.00168	0.00282	CcSEcCtD
Isradipine—Syncope—Methylprednisolone—psoriatic arthritis	0.00168	0.00282	CcSEcCtD
Isradipine—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00167	0.00281	CcSEcCtD
Isradipine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00166	0.00279	CcSEcCtD
Isradipine—Oedema—Prednisolone—psoriatic arthritis	0.00166	0.00279	CcSEcCtD
Isradipine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00165	0.00277	CcSEcCtD
Isradipine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00164	0.00276	CcSEcCtD
Isradipine—Shock—Prednisolone—psoriatic arthritis	0.00164	0.00275	CcSEcCtD
Isradipine—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00164	0.00275	CcSEcCtD
Isradipine—Cough—Triamcinolone—psoriatic arthritis	0.00163	0.00275	CcSEcCtD
Isradipine—Tachycardia—Prednisolone—psoriatic arthritis	0.00162	0.00273	CcSEcCtD
Isradipine—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00162	0.00272	CcSEcCtD
Isradipine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00161	0.0027	CcSEcCtD
Isradipine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00159	0.00267	CcSEcCtD
Isradipine—Eye disorder—Prednisone—psoriatic arthritis	0.00159	0.00267	CcSEcCtD
Isradipine—Anxiety—Methylprednisolone—psoriatic arthritis	0.00159	0.00267	CcSEcCtD
Isradipine—Drowsiness—Methotrexate—psoriatic arthritis	0.00158	0.00266	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00158	0.00266	CcSEcCtD
Isradipine—Depression—Methotrexate—psoriatic arthritis	0.00158	0.00265	CcSEcCtD
Isradipine—Flushing—Prednisone—psoriatic arthritis	0.00158	0.00265	CcSEcCtD
Isradipine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00158	0.00265	CcSEcCtD
Isradipine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00158	0.00265	CcSEcCtD
Isradipine—Discomfort—Triamcinolone—psoriatic arthritis	0.00158	0.00265	CcSEcCtD
Isradipine—Discomfort—Methylprednisolone—psoriatic arthritis	0.00157	0.00264	CcSEcCtD
Isradipine—Dry mouth—Triamcinolone—psoriatic arthritis	0.00156	0.00262	CcSEcCtD
Isradipine—Angioedema—Dexamethasone—psoriatic arthritis	0.00155	0.00261	CcSEcCtD
Isradipine—Angioedema—Betamethasone—psoriatic arthritis	0.00155	0.00261	CcSEcCtD
Isradipine—Angiopathy—Prednisone—psoriatic arthritis	0.00154	0.00259	CcSEcCtD
Isradipine—Immune system disorder—Prednisone—psoriatic arthritis	0.00154	0.00258	CcSEcCtD
Isradipine—Malaise—Betamethasone—psoriatic arthritis	0.00153	0.00258	CcSEcCtD
Isradipine—Malaise—Dexamethasone—psoriatic arthritis	0.00153	0.00258	CcSEcCtD
Isradipine—Oedema—Triamcinolone—psoriatic arthritis	0.00153	0.00257	CcSEcCtD
Isradipine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00153	0.00257	CcSEcCtD
Isradipine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00153	0.00256	CcSEcCtD
Isradipine—Syncope—Dexamethasone—psoriatic arthritis	0.00152	0.00256	CcSEcCtD
Isradipine—Syncope—Betamethasone—psoriatic arthritis	0.00152	0.00256	CcSEcCtD
Isradipine—Shock—Triamcinolone—psoriatic arthritis	0.0015	0.00253	CcSEcCtD
Isradipine—Insomnia—Prednisolone—psoriatic arthritis	0.0015	0.00253	CcSEcCtD
Isradipine—Shock—Methylprednisolone—psoriatic arthritis	0.0015	0.00252	CcSEcCtD
Isradipine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.0015	0.00252	CcSEcCtD
Isradipine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.0015	0.00251	CcSEcCtD
Isradipine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00149	0.00251	CcSEcCtD
Isradipine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00149	0.00251	CcSEcCtD
Isradipine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00149	0.00251	CcSEcCtD
Isradipine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00149	0.00251	CcSEcCtD
Isradipine—Mental disorder—Prednisone—psoriatic arthritis	0.00149	0.0025	CcSEcCtD
Isradipine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00149	0.0025	CcSEcCtD
Isradipine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00148	0.00249	CcSEcCtD
Isradipine—Malnutrition—Prednisone—psoriatic arthritis	0.00148	0.00249	CcSEcCtD
Isradipine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00148	0.00248	CcSEcCtD
Isradipine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00147	0.00248	CcSEcCtD
Isradipine—Anxiety—Dexamethasone—psoriatic arthritis	0.00144	0.00242	CcSEcCtD
Isradipine—Anxiety—Betamethasone—psoriatic arthritis	0.00144	0.00242	CcSEcCtD
Isradipine—Discomfort—Dexamethasone—psoriatic arthritis	0.00143	0.0024	CcSEcCtD
Isradipine—Discomfort—Betamethasone—psoriatic arthritis	0.00143	0.0024	CcSEcCtD
Isradipine—Hypotension—Methylprednisolone—psoriatic arthritis	0.00143	0.0024	CcSEcCtD
Isradipine—Hepatitis—Methotrexate—psoriatic arthritis	0.00142	0.00239	CcSEcCtD
Isradipine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.0014	0.00236	CcSEcCtD
Isradipine—Vision blurred—Prednisone—psoriatic arthritis	0.0014	0.00234	CcSEcCtD
Isradipine—Urethral disorder—Methotrexate—psoriatic arthritis	0.00139	0.00234	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00139	0.00234	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00139	0.00234	CcSEcCtD
Isradipine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00139	0.00233	CcSEcCtD
Isradipine—Oedema—Betamethasone—psoriatic arthritis	0.00139	0.00233	CcSEcCtD
Isradipine—Oedema—Dexamethasone—psoriatic arthritis	0.00139	0.00233	CcSEcCtD
Isradipine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00139	0.00233	CcSEcCtD
Isradipine—Insomnia—Triamcinolone—psoriatic arthritis	0.00138	0.00232	CcSEcCtD
Isradipine—Insomnia—Methylprednisolone—psoriatic arthritis	0.00138	0.00232	CcSEcCtD
Isradipine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00137	0.00231	CcSEcCtD
Isradipine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00137	0.00231	CcSEcCtD
Isradipine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00137	0.0023	CcSEcCtD
Isradipine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00137	0.0023	CcSEcCtD
Isradipine—Visual impairment—Methotrexate—psoriatic arthritis	0.00137	0.0023	CcSEcCtD
Isradipine—Anaemia—Prednisone—psoriatic arthritis	0.00137	0.0023	CcSEcCtD
Isradipine—Shock—Dexamethasone—psoriatic arthritis	0.00137	0.00229	CcSEcCtD
Isradipine—Shock—Betamethasone—psoriatic arthritis	0.00137	0.00229	CcSEcCtD
Isradipine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00136	0.00229	CcSEcCtD
Isradipine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00136	0.00229	CcSEcCtD
Isradipine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00136	0.00229	CcSEcCtD
Isradipine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00136	0.00228	CcSEcCtD
Isradipine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00136	0.00228	CcSEcCtD
Isradipine—Tachycardia—Dexamethasone—psoriatic arthritis	0.00135	0.00228	CcSEcCtD
Isradipine—Tachycardia—Betamethasone—psoriatic arthritis	0.00135	0.00228	CcSEcCtD
Isradipine—Angioedema—Prednisone—psoriatic arthritis	0.00135	0.00227	CcSEcCtD
Isradipine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00135	0.00226	CcSEcCtD
Isradipine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00134	0.00226	CcSEcCtD
Isradipine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00134	0.00225	CcSEcCtD
Isradipine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00134	0.00225	CcSEcCtD
Isradipine—Malaise—Prednisone—psoriatic arthritis	0.00134	0.00224	CcSEcCtD
Isradipine—Eye disorder—Methotrexate—psoriatic arthritis	0.00133	0.00223	CcSEcCtD
Isradipine—Syncope—Prednisone—psoriatic arthritis	0.00133	0.00223	CcSEcCtD
Isradipine—Urticaria—Prednisolone—psoriatic arthritis	0.00132	0.00222	CcSEcCtD
Isradipine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00132	0.00222	CcSEcCtD
Isradipine—Fatigue—Triamcinolone—psoriatic arthritis	0.00132	0.00222	CcSEcCtD
Isradipine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00132	0.00221	CcSEcCtD
Isradipine—Loss of consciousness—Prednisone—psoriatic arthritis	0.0013	0.00219	CcSEcCtD
Isradipine—Hypotension—Dexamethasone—psoriatic arthritis	0.0013	0.00218	CcSEcCtD
Isradipine—Hypotension—Betamethasone—psoriatic arthritis	0.0013	0.00218	CcSEcCtD
Isradipine—Angiopathy—Methotrexate—psoriatic arthritis	0.00129	0.00217	CcSEcCtD
Isradipine—Immune system disorder—Methotrexate—psoriatic arthritis	0.00128	0.00216	CcSEcCtD
Isradipine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00128	0.00215	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00126	0.00212	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00126	0.00212	CcSEcCtD
Isradipine—Arthralgia—Prednisone—psoriatic arthritis	0.00126	0.00212	CcSEcCtD
Isradipine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00126	0.00212	CcSEcCtD
Isradipine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00126	0.00211	CcSEcCtD
Isradipine—Anxiety—Prednisone—psoriatic arthritis	0.00126	0.00211	CcSEcCtD
Isradipine—Insomnia—Betamethasone—psoriatic arthritis	0.00125	0.00211	CcSEcCtD
Isradipine—Insomnia—Dexamethasone—psoriatic arthritis	0.00125	0.00211	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00125	0.0021	CcSEcCtD
Isradipine—Paraesthesia—Betamethasone—psoriatic arthritis	0.00125	0.00209	CcSEcCtD
Isradipine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00125	0.00209	CcSEcCtD
Isradipine—Discomfort—Prednisone—psoriatic arthritis	0.00125	0.00209	CcSEcCtD
Isradipine—Mental disorder—Methotrexate—psoriatic arthritis	0.00125	0.00209	CcSEcCtD
Isradipine—Malnutrition—Methotrexate—psoriatic arthritis	0.00124	0.00208	CcSEcCtD
Isradipine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00122	0.00205	CcSEcCtD
Isradipine—Dyspepsia—Betamethasone—psoriatic arthritis	0.00122	0.00205	CcSEcCtD
Isradipine—Urticaria—Triamcinolone—psoriatic arthritis	0.00121	0.00204	CcSEcCtD
Isradipine—Urticaria—Methylprednisolone—psoriatic arthritis	0.00121	0.00204	CcSEcCtD
Isradipine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00121	0.00203	CcSEcCtD
Isradipine—Oedema—Prednisone—psoriatic arthritis	0.00121	0.00203	CcSEcCtD
Isradipine—Decreased appetite—Betamethasone—psoriatic arthritis	0.00121	0.00203	CcSEcCtD
Isradipine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00121	0.00203	CcSEcCtD
Isradipine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.0012	0.00201	CcSEcCtD
Isradipine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.0012	0.00201	CcSEcCtD
Isradipine—Back pain—Methotrexate—psoriatic arthritis	0.0012	0.00201	CcSEcCtD
Isradipine—Fatigue—Dexamethasone—psoriatic arthritis	0.0012	0.00201	CcSEcCtD
Isradipine—Fatigue—Betamethasone—psoriatic arthritis	0.0012	0.00201	CcSEcCtD
Isradipine—Shock—Prednisone—psoriatic arthritis	0.00119	0.002	CcSEcCtD
Isradipine—Nervous system disorder—Prednisone—psoriatic arthritis	0.00118	0.00199	CcSEcCtD
Isradipine—Tachycardia—Prednisone—psoriatic arthritis	0.00118	0.00198	CcSEcCtD
Isradipine—Skin disorder—Prednisone—psoriatic arthritis	0.00117	0.00197	CcSEcCtD
Isradipine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00117	0.00196	CcSEcCtD
Isradipine—Vision blurred—Methotrexate—psoriatic arthritis	0.00117	0.00196	CcSEcCtD
Isradipine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00115	0.00193	CcSEcCtD
Isradipine—Anaemia—Methotrexate—psoriatic arthritis	0.00114	0.00192	CcSEcCtD
Isradipine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00114	0.00192	CcSEcCtD
Isradipine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00114	0.00192	CcSEcCtD
Isradipine—Malaise—Methotrexate—psoriatic arthritis	0.00112	0.00187	CcSEcCtD
Isradipine—Leukopenia—Methotrexate—psoriatic arthritis	0.00111	0.00186	CcSEcCtD
Isradipine—Urticaria—Dexamethasone—psoriatic arthritis	0.0011	0.00185	CcSEcCtD
Isradipine—Urticaria—Betamethasone—psoriatic arthritis	0.0011	0.00185	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.0011	0.00185	CcSEcCtD
Isradipine—Dizziness—Prednisolone—psoriatic arthritis	0.0011	0.00185	CcSEcCtD
Isradipine—Asthenia—Triamcinolone—psoriatic arthritis	0.0011	0.00184	CcSEcCtD
Isradipine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00109	0.00184	CcSEcCtD
Isradipine—Insomnia—Prednisone—psoriatic arthritis	0.00109	0.00184	CcSEcCtD
Isradipine—Paraesthesia—Prednisone—psoriatic arthritis	0.00108	0.00182	CcSEcCtD
Isradipine—Pruritus—Triamcinolone—psoriatic arthritis	0.00108	0.00182	CcSEcCtD
Isradipine—Cough—Methotrexate—psoriatic arthritis	0.00108	0.00181	CcSEcCtD
Isradipine—Pruritus—Methylprednisolone—psoriatic arthritis	0.00108	0.00181	CcSEcCtD
Isradipine—Dyspepsia—Prednisone—psoriatic arthritis	0.00106	0.00179	CcSEcCtD
Isradipine—Arthralgia—Methotrexate—psoriatic arthritis	0.00105	0.00177	CcSEcCtD
Isradipine—Chest pain—Methotrexate—psoriatic arthritis	0.00105	0.00177	CcSEcCtD
Isradipine—Decreased appetite—Prednisone—psoriatic arthritis	0.00105	0.00177	CcSEcCtD
Isradipine—Rash—Prednisolone—psoriatic arthritis	0.00105	0.00176	CcSEcCtD
Isradipine—Dermatitis—Prednisolone—psoriatic arthritis	0.00105	0.00176	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00105	0.00176	CcSEcCtD
Isradipine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00104	0.00175	CcSEcCtD
Isradipine—Fatigue—Prednisone—psoriatic arthritis	0.00104	0.00175	CcSEcCtD
Isradipine—Headache—Prednisolone—psoriatic arthritis	0.00104	0.00175	CcSEcCtD
Isradipine—Discomfort—Methotrexate—psoriatic arthritis	0.00104	0.00175	CcSEcCtD
Isradipine—Constipation—Prednisone—psoriatic arthritis	0.00103	0.00174	CcSEcCtD
Isradipine—Dizziness—Triamcinolone—psoriatic arthritis	0.00101	0.0017	CcSEcCtD
Isradipine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00101	0.0017	CcSEcCtD
Isradipine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00101	0.0017	CcSEcCtD
Isradipine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000996	0.00167	CcSEcCtD
Isradipine—Asthenia—Betamethasone—psoriatic arthritis	0.000995	0.00167	CcSEcCtD
Isradipine—Asthenia—Dexamethasone—psoriatic arthritis	0.000995	0.00167	CcSEcCtD
Isradipine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00099	0.00166	CcSEcCtD
Isradipine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000989	0.00166	CcSEcCtD
Isradipine—Nausea—Prednisolone—psoriatic arthritis	0.000988	0.00166	CcSEcCtD
Isradipine—Pruritus—Betamethasone—psoriatic arthritis	0.000982	0.00165	CcSEcCtD
Isradipine—Pruritus—Dexamethasone—psoriatic arthritis	0.000982	0.00165	CcSEcCtD
Isradipine—Skin disorder—Methotrexate—psoriatic arthritis	0.000981	0.00165	CcSEcCtD
Isradipine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000976	0.00164	CcSEcCtD
Isradipine—Vomiting—Triamcinolone—psoriatic arthritis	0.000972	0.00163	CcSEcCtD
Isradipine—Vomiting—Methylprednisolone—psoriatic arthritis	0.00097	0.00163	CcSEcCtD
Isradipine—Rash—Triamcinolone—psoriatic arthritis	0.000964	0.00162	CcSEcCtD
Isradipine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000963	0.00162	CcSEcCtD
Isradipine—Rash—Methylprednisolone—psoriatic arthritis	0.000962	0.00162	CcSEcCtD
Isradipine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000961	0.00162	CcSEcCtD
Isradipine—Urticaria—Prednisone—psoriatic arthritis	0.00096	0.00161	CcSEcCtD
Isradipine—Headache—Triamcinolone—psoriatic arthritis	0.000958	0.00161	CcSEcCtD
Isradipine—Headache—Methylprednisolone—psoriatic arthritis	0.000956	0.00161	CcSEcCtD
Isradipine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000949	0.0016	CcSEcCtD
Isradipine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000949	0.0016	CcSEcCtD
Isradipine—Hypotension—Methotrexate—psoriatic arthritis	0.000944	0.00159	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00092	0.00155	CcSEcCtD
Isradipine—Dizziness—Betamethasone—psoriatic arthritis	0.000918	0.00154	CcSEcCtD
Isradipine—Dizziness—Dexamethasone—psoriatic arthritis	0.000918	0.00154	CcSEcCtD
Isradipine—Insomnia—Methotrexate—psoriatic arthritis	0.000913	0.00153	CcSEcCtD
Isradipine—Nausea—Triamcinolone—psoriatic arthritis	0.000908	0.00153	CcSEcCtD
Isradipine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000907	0.00152	CcSEcCtD
Isradipine—Nausea—Methylprednisolone—psoriatic arthritis	0.000906	0.00152	CcSEcCtD
Isradipine—Dyspnoea—Methotrexate—psoriatic arthritis	0.0009	0.00151	CcSEcCtD
Isradipine—Somnolence—Methotrexate—psoriatic arthritis	0.000898	0.00151	CcSEcCtD
Isradipine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000889	0.00149	CcSEcCtD
Isradipine—Vomiting—Betamethasone—psoriatic arthritis	0.000882	0.00148	CcSEcCtD
Isradipine—Vomiting—Dexamethasone—psoriatic arthritis	0.000882	0.00148	CcSEcCtD
Isradipine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000878	0.00148	CcSEcCtD
Isradipine—Rash—Dexamethasone—psoriatic arthritis	0.000875	0.00147	CcSEcCtD
Isradipine—Rash—Betamethasone—psoriatic arthritis	0.000875	0.00147	CcSEcCtD
Isradipine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000874	0.00147	CcSEcCtD
Isradipine—Dermatitis—Betamethasone—psoriatic arthritis	0.000874	0.00147	CcSEcCtD
Isradipine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000872	0.00146	CcSEcCtD
Isradipine—Fatigue—Methotrexate—psoriatic arthritis	0.000871	0.00146	CcSEcCtD
Isradipine—Headache—Betamethasone—psoriatic arthritis	0.000869	0.00146	CcSEcCtD
Isradipine—Headache—Dexamethasone—psoriatic arthritis	0.000869	0.00146	CcSEcCtD
Isradipine—Asthenia—Prednisone—psoriatic arthritis	0.000867	0.00146	CcSEcCtD
Isradipine—Pruritus—Prednisone—psoriatic arthritis	0.000855	0.00144	CcSEcCtD
Isradipine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000832	0.0014	CcSEcCtD
Isradipine—Diarrhoea—Prednisone—psoriatic arthritis	0.000827	0.00139	CcSEcCtD
Isradipine—Nausea—Betamethasone—psoriatic arthritis	0.000824	0.00138	CcSEcCtD
Isradipine—Nausea—Dexamethasone—psoriatic arthritis	0.000824	0.00138	CcSEcCtD
Isradipine—Urticaria—Methotrexate—psoriatic arthritis	0.000802	0.00135	CcSEcCtD
Isradipine—Dizziness—Prednisone—psoriatic arthritis	0.000799	0.00134	CcSEcCtD
Isradipine—Vomiting—Prednisone—psoriatic arthritis	0.000768	0.00129	CcSEcCtD
Isradipine—Rash—Prednisone—psoriatic arthritis	0.000762	0.00128	CcSEcCtD
Isradipine—Dermatitis—Prednisone—psoriatic arthritis	0.000761	0.00128	CcSEcCtD
Isradipine—Headache—Prednisone—psoriatic arthritis	0.000757	0.00127	CcSEcCtD
Isradipine—Asthenia—Methotrexate—psoriatic arthritis	0.000725	0.00122	CcSEcCtD
Isradipine—Nausea—Prednisone—psoriatic arthritis	0.000718	0.00121	CcSEcCtD
Isradipine—Pruritus—Methotrexate—psoriatic arthritis	0.000714	0.0012	CcSEcCtD
Isradipine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000691	0.00116	CcSEcCtD
Isradipine—Dizziness—Methotrexate—psoriatic arthritis	0.000668	0.00112	CcSEcCtD
Isradipine—Vomiting—Methotrexate—psoriatic arthritis	0.000642	0.00108	CcSEcCtD
Isradipine—Rash—Methotrexate—psoriatic arthritis	0.000637	0.00107	CcSEcCtD
Isradipine—Dermatitis—Methotrexate—psoriatic arthritis	0.000636	0.00107	CcSEcCtD
Isradipine—Headache—Methotrexate—psoriatic arthritis	0.000633	0.00106	CcSEcCtD
Isradipine—Nausea—Methotrexate—psoriatic arthritis	0.0006	0.00101	CcSEcCtD
